NCT05241873 2025-02-10(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion MutationsBlueprint Medicines CorporationPhase 1 Terminated103 enrolled
NCT05153408 2023-06-18(HARMONY) Study of BLU-701 in EGFR-mutant NSCLCBlueprint Medicines CorporationPhase 1 Terminated20 enrolled
NCT03134872 2020-06-09A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLCJiangsu HengRui Medicine Co., Ltd.Phase 3 Completed419 enrolled
NCT02941601 2019-09-27A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)Eli Lilly and CompanyPhase 2 Withdrawn